Clinical trials
Phase 4 Carotid Artery Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 4 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 1 |
| Azienda Ospedaliera Ordine Mauriziano di Torino | 1 |
| Boston Scientific Corporation | 1 |
| Cynthia West | 1 |
| Instituto de Investigación Marqués de Valdecilla | 1 |
| Peking Union Medical College Hospital | 1 |
| Seoul National University Bundang Hospital | 1 |
| The University of Texas Health Science Center, Houston | 1 |
| Thomas Jefferson University | 1 |
| University of Campinas, Brazil | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carotid Artery Diseases | 12 |
| Atherosclerosis | 4 |
| Carotid Stenosis | 3 |
| Stroke | 3 |
| Coronary Artery Disease | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Arthritis, Psoriatic | 1 |
| Arthritis, Rheumatoid | 1 |
| Cardiovascular Diseases | 1 |
| Cerebral Infarction | 1 |
Trials
Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.